Repeated low-dose skin exposure is an effective sensitizing stimulus, a factor to be taken into account in predicting sensitization risk

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 594-597

  Paramasivan, P ^a   Lai, C ^a   Pickard, C ^a   Ardern Jones, M ^a   Healy, E ^a   Friedmann, P S ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Contact dermatitis; DNCB; Repeated exposure; Sensitising dose

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; IRRITANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTACT SENSITIZATION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN SENSITIZATION; SKINFOLD THICKNESS; ANALYSIS OF VARIANCE; DOSE RESPONSE; IMMUNOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SKIN TEST; TOXICITY; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; DERMATITIS, ALLERGIC CONTACT; DINITROCHLOROBENZENE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IRRITANTS; MALE; MIDDLE AGED; RISK ASSESSMENT; SKIN TESTS; YOUNG ADULT;

EID: 76949093231     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09489.x     Document Type: Article

References (17)

1. Friedmann PS, Moss C, Shuster S et al. Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 1983 53 : 709 711.
2. Friedmann PS. The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans. Br J Dermatol 2007 157 : 1093 1102.
3. Kligman AM. The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis. J Invest Dermatol 1966 47 : 375 392.
4. Basketter DA, Jefferies D, Safford BJ et al. The impact of exposure variables on the induction of skin sensitization. Contact Dermatitis 2006 55 : 178 185.
5. Pickard C, Smith AM, Cooper H et al. Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene. J Invest Dermatol 2007 127 : 630 637.
6. Rees JL, Friedmann PS. Area of application does affect strength of sensitization by DNCB. J Invest Dermatol 1988 91 : 404.
7. Cardin CW, Weaver JE, Bailey PT. Dose-response assessments of Kathon biocide. (II). Threshold prophetic patch testing. Contact Dermatitis 1986 15 : 10 16.
8. White SI, Friedmann PS, Moss C et al. The effect of altering area of application and dose per unit area on sensitization by DNCB. Br J Dermatol 1986 115 : 663 668.
9. White JM, Basketter DA, Pease CK et al. Intermittent exposure to low-concentration paraphenylenediamine can be equivalent to single, higher-dose exposure. Contact Dermatitis 2007 56 : 262 265.
10. Schnuch A, Kelterer D, Bauer A et al. Quantitative patch and repeated open application testing in methyldibromo glutaronitrile-sensitive patients. Contact Dermatitis 2005 52 : 197 206.
11. Johansen JD, Andersen KE, Menne T. Quantitative aspects of isoeugenol contact allergy assessed by use and patch tests. Contact Dermatitis 1996 34 : 414 418. (Pubitemid 26316922)
12. Zachariae C, Lerbaek A, McNamee PM et al. An evaluation of dose/unit area and time as key factors influencing the elicitation capacity of ethylchloroisothiazolinone/methylisothiazolinone (MCI/MI) in MCI/MI-allergic patients. Contact Dermatitis 2006 55 : 160 166.
13. Friedmann PS. Thresholds, dose-response relationships and dose metrics in allergic contact dermatitis. Br J Dermatol 2008 159 : 1381 1382.
14. Kimber I, Basketter D. Thresholds, dose-response relationships and dose metrics in allergic contact dermatitis. Br J Dermatol 2008 159 : 1380 1381.
15. Demoly P, Viola M, Gomes R et al. Epidemiology and causes of drug hypersensitivity. In : Drug Hypersensitivity (Pichler WJ, ed Basel : Karger, 2007 2 17.
16. Felter SP, Robinson MK, Basketter DA et al. A review of the scientific basis for uncertainty factors for use in quantitative risk assessment for the induction of allergic contact dermatitis. Contact Dermatitis 2002 47 : 257 266.
17. Basketter DA. Skin sensitization: strategies for the assessment and management of risk. Br J Dermatol 2008 159 : 267 273.